<SEC-DOCUMENT>0001108205-26-000059.txt : 20260512
<SEC-HEADER>0001108205-26-000059.hdr.sgml : 20260512
<ACCEPTANCE-DATETIME>20260512160142
ACCESSION NUMBER:		0001108205-26-000059
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260512
DATE AS OF CHANGE:		20260512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CURIS INC
		CENTRAL INDEX KEY:			0001108205
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				043505116
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30347
		FILM NUMBER:		26968303

	BUSINESS ADDRESS:	
		STREET 1:		128 SPRING STREET
		STREET 2:		BUILDING C, SUITE 500
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		617-503-6500

	MAIL ADDRESS:	
		STREET 1:		128 SPRING STREET
		STREET 2:		BUILDING C, SUITE 500
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cris-20260512.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e08ab-76a5-73a3-9801-806beb4373d7,g:af945873-f6ed-48c7-8cbd-70e050f72931,d:63cd6f331ec147b18a54e40541eb49e8-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cris-20260512</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001108205</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cris-20260512.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001108205</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-12</xbrli:startDate><xbrli:endDate>2026-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i63cd6f331ec147b18a54e40541eb49e8_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event Reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 12, 2026</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Curis, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.064%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.892%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-30347</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">04-3505116</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">128 Spring Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Building C - Suite 500</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Lexington</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">MA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">02421</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices) (Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">(617)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">503-6500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.074%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.945%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:36.717%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, Par Value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">CRIS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i63cd6f331ec147b18a54e40541eb49e8_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. Results of Operations and Financial Condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2026, Curis, Inc. announced its financial results for the three-month periods ended March 31, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i63cd6f331ec147b18a54e40541eb49e8_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:73.534%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1q26earningspressrelease.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1q26earningspressrelease.htm">May 12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1q26earningspressrelease.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1q26earningspressrelease.htm">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the InLine XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i63cd6f331ec147b18a54e40541eb49e8_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:12pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.755%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Curis, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;&#160;&#160;J</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">AMES</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> E. D</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">ENTZER&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">James E. Dentzer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a1q26earningspressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i08ea54936a3443d4871ee9ec1b580852_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:139%">Exhibit 99.1</font></div></div><div style="text-align:right"><img alt="image_0.jpg" src="image_0.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:116px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:139%">PRESS RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:139%">Curis Provides First Quarter 2026 Business Update</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management to host conference call today at 4&#58;30 p.m. ET</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEXINGTON, Mass., May 12, 2026 &#47;PRNewswire&#47; -- Curis, Inc. (NASDAQ&#58; CRIS</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, today reported its business update and financial results for the quarter ended March 31, 2026.</font></div><div style="text-align:justify"><font><br></font></div><div id="i08ea54936a3443d4871ee9ec1b580852_4"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational Highlights</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">TakeAim Lymphoma</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Emavusertib is currently undergoing testing in combination with the Bruton's tyrosine kinase inhibitor (BTKi) ibrutinib in the TakeAim Lymphoma Phase 1&#47;2 open-label, single arm expansion trial in patients with Relapsed or Refractory (R&#47;R) Primary CNS Lymphoma (PCNSL) (CA-4948-101, NCT03328078). Patient enrollment in this study is currently ongoing. As a result of discussions with FDA and EMA, the ongoing phase 1&#47;2 study is intended to support filings for accelerated approval of emavusertib in PCNSL in the US and Europe. Emavusertib has been granted orphan drug designation by both FDA and EMA in PCNSL.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">TakeAim CLL </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Emavusertib is also being tested in the recently initiated open label TakeAim CLL Phase 2 clinical trial of emavusertib in combination with the BTKi zanubrutinib in patients with Chronic Lymphocytic Leukemia (CLL) (CA-4948-203, NCT07271667). The goal of combining emavusertib with a BTKi is to enable a dual blockade of NF-kB, a key driver of disease in CLL and NHL, by inhibiting both the TLR and BCR pathways. The current standard of care is the use of BTK inhibitors, which block the BCR pathway and can deliver high response rates, though typically only partial responses. Previous clinical studies have shown that adding emavusertib, which blocks the TLR pathway, to a BTKi regimen can enable patients with NHL to achieve deeper responses, including complete remission or undetectable minimal residual disease (MRD) and the potential for time-limited treatment, outcomes which represent the potential for a paradigm shift in the management of CLL.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Solid Tumors</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dr. Patrick Grierson, Siteman Cancer Center, Washington University in St Louis, presented a poster with initial clinical data in gastric and esophageal cancer at the ASCO Gastrointestinal Cancers Symposium in January 2026. In this study, patients are treated with emavusertib in combination with FOLFOX and anti-PD1 +&#47;- trastuzumab as first-line therapy for metastatic or unresectable gastroesophageal cancers. The poster titled </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A phase I trial of emavusertib (CA-4948) in combination with FOLFOX&#47; PD-1 inhibitor +&#47;- trastuzumab as first-line treatment for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">untreated unresectable gastric and esophageal cancer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> showed results for 16 evaluable patients demonstrating a manageable toxicity profile and encouraging preliminary results. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dr. Patrick Grierson, Siteman Cancer Center, Washington University in St Louis will have an abstract titled </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A phase I trial of emavusertib (CA-4948) in combination with gemcitabine and nab-paclitaxel in metastatic or unresectable pancreatic ductal adenocarcinoma (PDAC) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available online at http&#58;&#47;&#47;asco.org&#47;abstracts on May 21, 2026 at 5&#58;00 PM EDT. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Upcoming Milestones</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Curis expects to announce the dosing of the initial 5 patients in the TakeAim CLL combination study with zanubrutinib by mid-2026, with data expected in December 2026.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Also, the Company expects updated emavusertib clinical data from the TakeAim Lymphoma combination study with ibrutinib in patients with R&#47;R PCNSL in the first half of 2027.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 9, 2026, the Company announced the closing of a private placement (the &#34;January 2026 PIPE Financing&#34;) with gross proceeds of up to $80.8 million, including initial gross proceeds of approximately $20.2 million with three series of warrants (A, B, and C) which can be exercised for up to $20.2 million each according to the terms and conditions of the financing agreement. All three series of warrants are exercisable at $0.75 per share, subject to conditions defined in the financing agreement with respect to the Series B warrants, and have the following termination conditions&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Series A warrants terminate on January 8, 2031&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Series B warrants terminate 30 days after the Company announces dosing of the fifth patient in the Phase 2 clinical trial in CLL, subject to conditions defined in the financing agreement&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Series C warrants terminate on July 8, 2027.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2026 Financial Results </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarter ended March 31, 2026, Curis reported a net loss of $24.2 million, or $1.25 per share on both a basic and diluted basis, as compared to a net loss of $10.6 million, or $1.25 per share on both a basic and diluted basis in 2025. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no revenues for the quarter ended March 31, 2026 due to the sale of Erivedge</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties to Oberland in the fourth quarter of 2025. Revenues, net were $2.4 million for the quarter ended March 31, 2025, comprising royalty revenues from Genentech and Roche's net sales of Erivedge</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $6.4 million and $8.5 million for the quarters ended March 31, 2026 and 2025, respectively. The decrease was primarily attributable to lower employee related and manufacturing costs. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $5.1 million and $4.0 million for the quarters ended March 31, 2026 and 2025, respectively. The increase was primarily attributable to expenses associated with the January 2026 PIPE Financing, partially offset by lower employee related costs. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was $12.7 million and $0.5 million for the quarters ended March 31, 2026 and 2025, respectively. The increase was attributable to the change in fair value of the warrant liability associated with the January 2026 PIPE Financing, partially offset by no expense related to the sale of future royalties in 2026.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, Curis's cash and cash equivalents totaled $15.0 million, and the Company had approximately 40.0 million shares of common stock outstanding. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Runway Guidance</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Curis believes its cash and cash equivalents as of March 31, 2026 of $15.0 million, together with anticipated gross proceeds of up to an additional $20.2 million from the exercise of the January 2026 PIPE Financing Series B Warrants upon the public announcement of dosing the 5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CLL patient in our TakeAim CLL study expected later this year, should enable the Company&#8217;s planned operations into the second half of 2027. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conference Call Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Curis management will host a conference call today, May 12, 2026, at 4&#58;30 p.m. ET, to discuss the business update and these financial results.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To access the live conference call, please dial </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(800)-836-8184 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from the United States or </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(646)-357-8785 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from other locations, shortly before 4&#58;30 p.m. ET. The conference call can also be accessed on the Curis website in the Investors section.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Curis, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Curis is a biotechnology company focused on the development of emavusertib, an orally available, small molecule IRAK4 and FLT3 inhibitor. Emavusertib is currently being evaluated in the TakeAim Lymphoma Phase 1&#47;2 study (CA-4948-101) of emavusertib in combination with the BTK inhibitor, ibrutinib, in patients with relapsed&#47;refractory primary central nervous system lymphoma (PCNSL) and in the TakeAim CLL Phase 2 study (CA-4948-203) of emavusertib in combination with the BTK inhibitor, zanubrutinib, in chronic lymphocytic leukemia (CLL). The Company&#8217;s monotherapy and combination studies in acute myeloid leukemia (AML) are substantially complete, with additional funding the Company plans to continue development of emavusertib in AML. Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL. Curis, through its 2015 collaboration with Aurigene Discovery Technologies Limited, has the exclusive license to emavusertib (CA-4948). For more information, visit Curis's website at www.curis.com.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements concerning Curis&#8217;s cash runway or expectations with respect to the timing or exercise of the January 2026 PIPE Financing Series B Warrants&#59; Curis's expectations with respect to the dosing of the first five patients in the TakeAim CLL study, and the therapeutic potential of emavusertib in combination with zanubrutinib to improve treatment outcomes, achieve complete remissions and&#47;or undetectable MRD, and&#47;or reduce time on treatment for patients with CLL&#59; Curis's expectations with respect to enrollment of BTKi na&#239;ve and BTKi experienced populations in the TakeAim Lymphoma study&#59; statements regarding updated PCNSL data and the timing of such data from the TakeAim Lymphoma study, or the use of such data to support regulatory filings for approval of emavusertib in PCNSL, and the therapeutic potential and tolerability of emavusertib in patients with PCNSL. Forward-looking statements may contain the words &#34;believes,&#34; &#34;expects,&#34; &#34;anticipates,&#34; &#34;plans,&#34; &#34;intends,&#34; &#34;seeks,&#34; &#34;estimates,&#34; &#34;assumes,&#34; &#34;predicts,&#34; &#34;projects,&#34; &#34;targets,&#34; &#34;will,&#34; &#34;may,&#34; &#34;would,&#34; &#34;could,&#34; &#34;should,&#34; &#34;likelihood&#34;, &#34;continue,&#34; &#34;potential,&#34; &#34;opportunity,&#34; &#34;focus,&#34; &#34;strategy,&#34; &#34;mission,&#34; or similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other important factors that may cause actual results to be materially different from those indicated by such forward-looking statements. Curis may experience adverse results, delays and&#47;or failures in its drug development programs and may not be able to successfully advance the development of its drug candidates in the time frames it projects, if at all. Curis's drug candidates may cause unexpected toxicities, fail to demonstrate sufficient safety and efficacy in clinical studies and&#47;or may never achieve the requisite regulatory approvals needed for commercialization. Favorable results seen in preclinical studies and early clinical trials of Curis's drug </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidates may not be replicated in later trials. Curis is dependent on the success of emavusertib and any delays in the development of emavusertib could have a material adverse effect on its business. There can be no guarantee that the collaboration agreement with Aurigene or the CRADA with NCI will continue for their full terms, that Curis or its collaborators will each maintain the financial and other resources necessary to continue financing its portion of the research, development and commercialization costs, or that the parties will successfully discover, develop or commercialize drug candidates under the collaboration. Curis will require substantial additional capital to fund its business. Based on its available cash resources, it does not have sufficient cash on hand to support current operations within the next 12 months from the date of this press release. Curis will require substantial additional funding to fund the development of emavusertib through regulatory approval and commercialization, and to support its continued operations. If it is not able to obtain sufficient funding, it will be forced to delay, reduce in scope or eliminate the development of emavusertib, including related clinical trials and operating expenses, potentially delaying the time to market for, or preventing the marketing of, emavusertib, which could adversely affect its business prospects and its ability to continue operations, and would have a negative impact on its financial condition and its ability to pursue its business strategies. Curis faces substantial competition. Curis and its collaborators face the risk of potential adverse decisions made by the FDA, EMA and other regulatory authorities, investigational review boards, and publication review bodies. Curis may not obtain or maintain necessary patent protection and could become involved in expensive and time-consuming patent litigation and interference proceedings. Unstable market and economic conditions, natural disasters, public health crises, political crises and other events outside of Curis's control, including its ability to regain and maintain its listing on the Nasdaq Capital Market, could significantly disrupt its operations or the operations of third parties on which Curis depends and could adversely impact Curis's operating results and its ability to raise capital. Other important factors that may cause or contribute to actual results being materially different from those indicated by forward-looking statements include the factors set forth under the captions &#34;Risk Factor Summary&#34; and &#34;Risk Factors&#34; in our most recent Form 10-K, and the factors that are discussed in other filings that Curis periodically makes with the Securities and Exchange Commission. In addition, any forward-looking statements represent the views of Curis only as of today and should not be relied upon as representing Curis's views as of any subsequent date. Curis disclaims any intention or obligation to update any of the forward-looking statements after the date of this press release whether as a result of new information, future events or otherwise, except as may be required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For further information&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Investor Relations&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IR&#64;curis.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</font></div><div style="text-align:center"><font><br></font></div><div style="padding-right:-13.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.615%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of royalties</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,539&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,070&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,984&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,519&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,537&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,519)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,157)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,680)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,199)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,616)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share (basic and diluted)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.25)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.25)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares (basic and diluted)</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,363,478&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,493,886&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:47.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.896%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:3.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,001</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,061</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,553</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,686</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,966</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,745</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,886</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.27pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,979</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,504</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,707</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,686</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,966</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cris-20260512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e08ab-76a5-73a3-9801-806beb4373d7,g:af945873-f6ed-48c7-8cbd-70e050f72931-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cris="http://www.curis.com/20260512" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.curis.com/20260512">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cris-20260512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cris-20260512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.curis.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cris-20260512_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e08ab-76a5-73a3-9801-806beb4373d7,g:af945873-f6ed-48c7-8cbd-70e050f72931-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019e08ab-76a6-7990-bfa9-6a1b566cfaf8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019e08ab-76a6-7281-aff3-7d414aa6ccca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e08ab-76a6-78ec-b169-3fdbb281c6d1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019e08ab-76a6-7fb8-9595-0cb1dd08f155_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019e08ab-76a6-75d1-b8a0-0a121e30818a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e08ab-76a6-711f-99ea-7bb4cacdff90_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_019e08ab-76a6-7f81-8ba5-6083b5110a7c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e08ab-76a6-70a9-830b-7ff5bd61cd72_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e08ab-76a6-7602-8b56-f864ae25eb75_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e08ab-76a6-75a2-8eea-753649842fa1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e08ab-76a6-78ad-ae42-2937ec733880_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019e08ab-76a6-7501-9bce-e0952b848e0e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e08ab-76a6-7163-83f9-5fdb55a973dc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e08ab-76a6-7216-b000-fac54fc11132_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019e08ab-76a6-7b9d-8133-7648128c48f0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019e08ab-76a6-79b4-a979-890475782e5c_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019e08ab-76a6-7432-8c1e-4f4196f9efde_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019e08ab-76a6-75f1-a8ed-5eb68b88b681_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e08ab-76a6-79c7-8ec2-481fd44b4059_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019e08ab-76a6-70ad-b578-e83f29f48542_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019e08ab-76a6-76c1-9794-902f360035d5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e08ab-76a6-7ba0-b686-85086ee20cd2_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019e08ab-76a6-7894-bf07-a3552a0d6528_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cris-20260512_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e08ab-76a5-73a3-9801-806beb4373d7,g:af945873-f6ed-48c7-8cbd-70e050f72931-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.curis.com/role/CoverPage" xlink:type="simple" xlink:href="cris-20260512.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.curis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e08ab-76a6-7173-99c5-a05cb182ae8e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_DocumentType_019e08ab-76a6-7173-99c5-a05cb182ae8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e08ab-76a6-74c8-ba27-120d72c6492e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityRegistrantName_019e08ab-76a6-74c8-ba27-120d72c6492e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e08ab-76a6-7ab4-8f1f-25cbf9d6d48c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e08ab-76a6-7ab4-8f1f-25cbf9d6d48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e08ab-76a6-7fae-ab13-fe35393d735c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityFileNumber_019e08ab-76a6-7fae-ab13-fe35393d735c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e08ab-76a6-79cf-b918-f7a885296e21" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e08ab-76a6-79cf-b918-f7a885296e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e08ab-76a6-7878-b6dc-86cec57e37da" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityAddressAddressLine1_019e08ab-76a6-7878-b6dc-86cec57e37da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019e08ab-76a6-72cf-9c94-c36c6c7d9405" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityAddressAddressLine2_019e08ab-76a6-72cf-9c94-c36c6c7d9405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e08ab-76a6-7dfe-9c6a-a52e9028d729" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityAddressCityOrTown_019e08ab-76a6-7dfe-9c6a-a52e9028d729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e08ab-76a6-7a5b-b0c7-2c4f6adb1660" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityAddressStateOrProvince_019e08ab-76a6-7a5b-b0c7-2c4f6adb1660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e08ab-76a6-7a52-ac3e-3bf9a87d2daa" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityAddressPostalZipCode_019e08ab-76a6-7a52-ac3e-3bf9a87d2daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e08ab-76a6-7a58-9110-20697523b93d" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_CityAreaCode_019e08ab-76a6-7a58-9110-20697523b93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e08ab-76a6-7a73-b108-1f4897b85a7b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_LocalPhoneNumber_019e08ab-76a6-7a73-b108-1f4897b85a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019e08ab-76a6-7fee-9596-83f5088e1ea8" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_WrittenCommunications_019e08ab-76a6-7fee-9596-83f5088e1ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019e08ab-76a6-7947-8a2d-06ea7160a392" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_SolicitingMaterial_019e08ab-76a6-7947-8a2d-06ea7160a392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019e08ab-76a6-7c78-a5ff-10e46c695b70" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_PreCommencementTenderOffer_019e08ab-76a6-7c78-a5ff-10e46c695b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019e08ab-76a6-73a4-830b-c7fa93a31202" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019e08ab-76a6-73a4-830b-c7fa93a31202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e08ab-76a6-71b2-967e-2ecb61bc4e77" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_Security12bTitle_019e08ab-76a6-71b2-967e-2ecb61bc4e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e08ab-76a6-76a1-b2af-0a8bd82bf6dd" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_TradingSymbol_019e08ab-76a6-76a1-b2af-0a8bd82bf6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e08ab-76a6-7c49-ac33-e5ba6183354c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e08ab-76a6-7c49-ac33-e5ba6183354c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e08ab-76a6-761d-aa93-5f1054799897" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_EntityCentralIndexKey_019e08ab-76a6-761d-aa93-5f1054799897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e08ab-76a6-737a-9195-3cc9234b8e86" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_AmendmentFlag_019e08ab-76a6-737a-9195-3cc9234b8e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e08ab-76a6-7e87-b837-de5d1ccdd698" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_SecurityExchangeName_019e08ab-76a6-7e87-b837-de5d1ccdd698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e08ab-76a6-7c27-86c4-54fac8eec0e5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e08ab-76a6-73f5-b2d4-368341f413ce" xlink:to="loc_dei_DocumentPeriodEndDate_019e08ab-76a6-7c27-86c4-54fac8eec0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "* 0L# 2(  A$! Q$!_\0
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M<U4Y=KZ>B2UD_P /(_'\9QKQ-Q'B)8?)*3C'NE>7JV](_P!:GDOQ:_X*N?\
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M7!S2U\>?=&3XQ\/7GBSPS>>'[#Q5J6BS74>Q=4TCR?M-OR,F/SHY$!(XR4.
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MNKX@7WAK5]:&DWFFZY=6\DUI<-"\L9618UWJPBFS\ORX'/(K]6" >37YW_\
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MMJ\+,L1'%9A6K1VE*37HVV?193AYX3*Z%">\813]4D@K\[_^#EK)_84\-_\
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MB&,#QW%D G'+>;>0\<?+N.>,'[PT?3K;2=+M]*LXMD-M;K%"NXG:JK@#)Y/
MKA?VKO@;IW[2_P"SIXR^!6INJ+XDT&>TAED^[%,5S$_0XVR!6R 2,<<UU91B
MHY?FE&N]HR3?I?7\#CSO!RS+):V'6\X-+UMI^)^,_P#P;B^+M.\-_M^7VB7K
M8FU[X?W]E9^\BW%K<'_QR!Z_=ZOYB_V?/B7\0/\ @GU^VOH_C+Q?X?O+/5O
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<UI7E)W;/TS!X/#Y?A88>A'EA%62"BBBN<ZC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 12, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Curis, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3505116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">128 Spring Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building C - Suite 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lexington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">503-6500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRIS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001108205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cris-20260512.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.curis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cris-20260512.htm">cris-20260512.htm</File>
    <File>cris-20260512.xsd</File>
    <File>cris-20260512_lab.xml</File>
    <File>cris-20260512_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cris-20260512.htm": {
   "nsprefix": "cris",
   "nsuri": "http://www.curis.com/20260512",
   "dts": {
    "inline": {
     "local": [
      "cris-20260512.htm"
     ]
    },
    "schema": {
     "local": [
      "cris-20260512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cris-20260512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cris-20260512_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 23
   },
   "report": {
    "R1": {
     "role": "http://www.curis.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cris-20260512.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cris-20260512.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001108205-26-000059-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001108205-26-000059-xbrl.zip
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M$S: 72" 3<1S63@2S!)WPO;&Q'EOP(3#[^ RP%*?O3_JE1K=1@<?YC+/!R$
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ML1KHES0H>WWP/K(U_$5,L:@V$TS&\K*G5O$_K78_7Y&9*S-5-6\J:S=3]O9
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MN%SA:U_$%@X)K<WO-]>0^REGV%L]WZ[$A7 #+.A!_$B)N^RP8ZN3IJ/N.+6
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M'O(.D9*:=O7IO$-91VF]<1ACOV;!>,_V_\]VT1GV"[Z:_ %02P,$%     @
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MBJ)H6K_ZVG21JAK*L&CZQV\75_2.S0E,\T5)<EH)+-+C1?WD14%)6??ZSKQ
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M[,9DB$4S4DS=&0'39\.*F4ZPT;#IL]$DI[>-.3Q5"3:[O"ORGF%(D" 88^)
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MBG:^6#PP<5WMQQ/?.%<4Y!T$HY@RR)PH<&/L8^8P74IVB1T8'"D/:4,?+!,
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M1)N?QH4\.OVP?B9=_HCLZ8?_ 5!+ P04    "  T@*Q<=\KFJ04&  #^,@
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M='NV8:/9=C ,N 797<S>:'@S;HAXYC8<[3WLJ%ZJOTL<[?T#4$L! A0#%
M  @ -("L7/AY&KH:'P  =Q$! !T              ( !     &$Q<3(V96%R
M;FEN9W-P<F5S<W)E;&5A<V4N:'1M4$L! A0#%     @ -("L7/=TZ,P8#P
MU'0  !$              ( !51\  &-R:7,M,C R-C U,3(N:'1M4$L! A0#
M%     @ -("L7.(1$V9C @  _08  !$              ( !G"X  &-R:7,M
M,C R-C U,3(N>'-D4$L! A0#%     @ -("L7/CC":!H"0  %%@  !4
M         ( !+C$  &-R:7,M,C R-C U,3)?;&%B+GAM;%!+ 0(4 Q0    (
M #2 K%QWRN:I!08  /XR   5              "  <DZ  !C<FES+3(P,C8P
A-3$R7W!R92YX;6Q02P4&      4 !0!/ 0   4$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>cris-20260512_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cris-20260512.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001108205</identifier>
        </entity>
        <period>
            <startDate>2026-05-12</startDate>
            <endDate>2026-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001108205</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Curis, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-30347</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">04-3505116</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">128 Spring Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Building C - Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Lexington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">02421</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">503-6500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, Par Value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">CRIS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
